BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20350764)

  • 1. Indoleamine 2,3-dioxygenase expression predicts impaired survival of invasive cervical cancer patients treated with radical hysterectomy.
    Inaba T; Ino K; Kajiyama H; Shibata K; Yamamoto E; Kondo S; Umezu T; Nawa A; Takikawa O; Kikkawa F
    Gynecol Oncol; 2010 Jun; 117(3):423-8. PubMed ID: 20350764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer.
    Ino K; Yoshida N; Kajiyama H; Shibata K; Yamamoto E; Kidokoro K; Takahashi N; Terauchi M; Nawa A; Nomura S; Nagasaka T; Takikawa O; Kikkawa F
    Br J Cancer; 2006 Dec; 95(11):1555-61. PubMed ID: 17117179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
    Watari H; Ohta Y; Hassan MK; Xiong Y; Tanaka S; Sakuragi N
    Gynecol Oncol; 2008 Mar; 108(3):527-32. PubMed ID: 18177691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early stage cervical cancer: adjuvant treatment in negative lymph node cases.
    Sartori E; Tisi G; Chiudinelli F; La Face B; Franzini R; Pecorelli S
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S170-4. PubMed ID: 17765298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inverse correlation between tumoral indoleamine 2,3-dioxygenase expression and tumor-infiltrating lymphocytes in endometrial cancer: its association with disease progression and survival.
    Ino K; Yamamoto E; Shibata K; Kajiyama H; Yoshida N; Terauchi M; Nawa A; Nagasaka T; Takikawa O; Kikkawa F
    Clin Cancer Res; 2008 Apr; 14(8):2310-7. PubMed ID: 18413819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume.
    Trattner M; Graf AH; Lax S; Forstner R; Dandachi N; Haas J; Pickel H; Reich O; Staudach A; Winter R
    Gynecol Oncol; 2001 Jul; 82(1):11-6. PubMed ID: 11426955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and prognostic significance of COX-2 expression in stage IB cervical cancer.
    Manchana T; Triratanachat S; Sirisabya N; Vasuratna A; Termrungruanglert W; Tresukosol D
    Gynecol Oncol; 2006 Mar; 100(3):556-60. PubMed ID: 16246405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.
    Aoki Y; Sasaki M; Watanabe M; Sato T; Tsuneki I; Aida H; Tanaka K
    Gynecol Oncol; 2000 May; 77(2):305-9. PubMed ID: 10785483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-hysterectomy radiotherapy in FIGO stage IB-IIB uterine cervical carcinoma.
    Kim JH; Kim HJ; Hong S; Wu HG; Ha SW
    Gynecol Oncol; 2005 Feb; 96(2):407-14. PubMed ID: 15661229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in stage IB-IIB cervical adenocarcinoma patients treated with radical hysterectomy and pelvic lymphadenectomy.
    Kodama J; Seki N; Masahiro S; Kusumoto T; Nakamura K; Hongo A; Hiramatsu Y
    J Surg Oncol; 2010 Apr; 101(5):413-7. PubMed ID: 20127891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in pathologic parametrium-positive patients with stage IB-IIB cervical cancer treated by radical surgery and adjuvant therapy.
    Kodama J; Seki N; Nakamura K; Hongo A; Hiramatsu Y
    Gynecol Oncol; 2007 Jun; 105(3):757-61. PubMed ID: 17433424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer.
    Hashimoto I; Kodama J; Seki N; Hongo A; Yoshinouchi M; Okuda H; Kudo T
    Br J Cancer; 2001 Jul; 85(1):93-7. PubMed ID: 11437408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer.
    Havrilesky LJ; Leath CA; Huh W; Calingaert B; Bentley RC; Soper JT; Alvarez Secord A
    Gynecol Oncol; 2004 May; 93(2):429-34. PubMed ID: 15099957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radical hysterectomy with pelvic lymphadenectomy in patients with carcinoma of the uterine cervix--3 years' experience].
    Bosković V; Glisić A; Petković S
    Srp Arh Celok Lek; 1998; 126(5-6):183-7. PubMed ID: 9863378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated full-thickness cervical stromal invasion warrants post-hysterectomy pelvic radiotherapy in FIGO stages IB-IIA uterine cervical carcinoma.
    Moon SH; Wu HG; Ha SW; Lee HP; Kang SB; Song YS; Park NH; Kim JW; Park IA; Kim BH
    Gynecol Oncol; 2007 Jan; 104(1):152-7. PubMed ID: 16935323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The outcome of laparoscopic radical hysterectomy and lymphadenectomy for cervical cancer: a prospective analysis of 295 patients.
    Chen Y; Xu H; Li Y; Wang D; Li J; Yuan J; Liang Z
    Ann Surg Oncol; 2008 Oct; 15(10):2847-55. PubMed ID: 18649105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
    Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy.
    Gadducci A; Teti G; Barsotti C; Tana R; Fanucchi A; Orlandini C; Fabrini MG; Genazzani AR
    Anticancer Res; 2010 Jan; 30(1):201-8. PubMed ID: 20150636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy.
    Hwang YY; Moon H; Cho SH; Kim KT; Moon YJ; Kim SR; Kim DS
    Gynecol Oncol; 2001 Jul; 82(1):88-93. PubMed ID: 11426967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.
    Tsai CS; Lai CH; Wang CC; Chang JT; Chang TC; Tseng CJ; Hong JH
    Gynecol Oncol; 1999 Dec; 75(3):328-33. PubMed ID: 10600284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.